AWM
ALT icon

Apollon Wealth Management’s Altimmune ALT Stock Holding History

Apollon Wealth Management’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-26,483
Closed -$310K – 817
2022
Q2 		$310K Hold
26,483
– – 0.03% 553
2022
Q1 		$161K Sell
26,483
-14,100
-35% -$104K 0.01% 707
2021
Q4 		$372K Sell
40,583
-3,400
-8% -$36.1K 0.03% 531
2021
Q3 		$497K Sell
43,983
-600
-1% -$7.3K 0.07% 267
2021
Q2 		$439K Buy
+44,583
New +$610K 0.08% 233

Other funds holding ALT

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Apollon Wealth Management's ALT Position: Q3 2022 in Review

Apollon Wealth Management sold out of Altimmune (ALT) in Q3 2022, closing a stake of 26,483 shares — an estimated $310K sold.

Apollon Wealth Management first reported a position in ALT in Q2 2021 and held it in 5 quarters. The position peaked at $497K in Q3 2021. 122 funds tracked by Wall St. Rank hold ALT as of Q3 2022.

  • Apollon Wealth Management reported no remaining Altimmune position as of Q3 2022 after selling out during the quarter.
  • Apollon Wealth Management sold 26,483 Altimmune shares in Q3 2022, an estimated $310K.
  • Apollon Wealth Management first reported a position in Altimmune in Q2 2021 and held it in 5 quarters.
  • Apollon Wealth Management's Altimmune position peaked at $497K in Q3 2021.
  • 122 funds tracked by Wall St. Rank held Altimmune as of Q3 2022.

Based on Apollon Wealth Management's 13F filing for Q3 2022, filed 8 Nov 2022.